Year: 2026
Type: article
Study design: Observational Study
Abstract: Concurrent chemoradiotherapy (cCRT) followed by durvalumab is the standard of care for unresectable stage III non–small cell lung cancer (NSCLC). The PACIFIC-R study highlighted the need for careful monitoring of radiation pneumonitis (RP) in real world setting. Purpose:To identify clinical and dosimetric factors associated with the risk of grade (G) ≥2 RP in patients treated according to a PACIFIC protocol in real world setting.
Source: ESMO Open
Author: B.B. Wassila
Institution: Hôpital Intercommunal de Créteil
Language: English
Subfield: Pulmonary and Respiratory Medicine
Field: Medicine
Domain: Health Sciences
Open Access status: gold
Estimated APC paid: $3,910
OpenAlex ID: W7138000635
FWCI:
Cites:
Cited by:
Related to: